Results 1 to 10 of about 4,378 (155)
TFII-I/Gtf2i and Erythro-Megakaryopoiesis [PDF]
TFII-I is a ubiquitously expressed transcription factor that positively or negatively regulates gene expression. TFII-I has been implicated in neuronal and immunologic diseases as well as in thymic epithelial cancer.
Zhijian Qian +2 more
exaly +6 more sources
Role of Rho-GTPases in megakaryopoiesis [PDF]
Megakaryocytes (MKs) are the bone marrow (BM) cells that generate blood platelets by a process that requires: i) polyploidization responsible for the increased MK size and ii) cytoplasmic organization leading to extension of long pseudopods, called proplatelets, through the endothelial barrier to allow platelet release into blood.
Hana Rašlová +2 more
exaly +3 more sources
CSF1R modulates megakaryopoiesis by targeting RUNX1 in immune thrombocytopenia [PDF]
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by platelet destruction and defective megakaryopoiesis. However, the mechanisms underlying megakaryocyte (MK) dysfunction in ITP remain unclear. To address this, we performed
Haohao Han +10 more
doaj +2 more sources
JMJD1C Regulates Megakaryopoiesis in In Vitro Models through the Actin Network
The histone demethylase JMJD1C is associated with human platelet counts. The JMJD1C knockout in zebrafish and mice leads to the ablation of megakaryocyte–erythroid lineage anemia.
Zhen Hu, Hu Zhenbo, Lili Qin
exaly +3 more sources
Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis
Autophagy is an effective strategy for cell development by recycling cytoplasmic constituents. Genetic deletion of autophagy mediator Atg7 in hematopoietic stem cells (HSCs) can lead to failure of megakaryopoiesis and enhanced autophagy has been ...
Mortimer Poncz, Li Zhu, Hongqiong Fan
exaly +2 more sources
Thrombocytopenia is a severe complication for patients with myelodysplastic syndrome (MDS). Eltrombopag increases platelet count in MDS patients but its combination with azacitidine elicited controversial results.
Marianna Criscuolo +2 more
exaly +2 more sources
Heterozygous nonsense FLI1 p.Met100∗ variant results in thrombocytopenia and increased erythroid gene expression [PDF]
Background: Megakaryocytes and platelets arise from hematopoietic stem and progenitor cells through a tightly regulated process involving various transcription factors, including erythroblast transformation–specific family member FLI1.
Huan Zhang +49 more
doaj +2 more sources
Direct megakaryopoiesis. [PDF]
Purpose of review Megakaryocytes are large, polyploid cells that produce platelets and originate from hematopoietic stem cells (HSCs) in the bone marrow. While in the classical paradigm, megakaryocytes are generated in a stepwise fashion through increasingly committed progenitor stages, studies using in-vivo barcoding ...
Snoeck HW.
europepmc +3 more sources
Summary: Human pluripotent stem cells (hPSCs) provide an unlimited source for generating various kinds of functional blood cells. However, efficient strategies for generating large-scale functional blood cells from hPSCs are still lacking, and the ...
Lihong Shi, Mengge Wang, Jie Gao
exaly +3 more sources
The Hippo-p53 pathway in megakaryopoiesis
Megakaryocytes are among the largest and rarest cells in the body, accounting for approximately 0.01% of nucleated cells in the bone marrow. Their differentiation involves a progression from hematopoietic stem cell to the megakaryocyte progenitor and finally to platelets.[1][1] A key step in ...
Praveen K Suraneni, John D. Crispino
doaj +3 more sources

